Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type i

Bone Marrow Transplantation

Volumn 46, Issue 4, 2011, Pages 562-566

  Snarski, E ^a   Milczarczyk, A ^b   Torosian, T ^a   Paluszewska, M ^a   Urbanowska, E ^a   Krol M ^a   Boguradzki, P ^a   Jedynasty, K ^b   Franek, E ^b,c   Wiktor Jedrzejczak, W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Central Hospital   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

diabetes; hematopoietic stem cells; immune ablation

Indexed keywords

ACARBOSE; ACICLOVIR; CETIRIZINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN A1C; INSULIN; THYMOCYTE ANTIBODY;

ABLATION THERAPY; ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CD34 SELECTION; CLINICAL ARTICLE; DRUG FEVER; DRUG HYPERSENSITIVITY; FEBRILE NEUTROPENIA; FEMALE; GLYCEMIC CONTROL; HEMATOPOIETIC STEM CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LEUKAPHERESIS; LOW DRUG DOSE; MALE; NAUSEA; PLASMAPHERESIS; PRIORITY JOURNAL; STEM CELL MOBILIZATION; VIRUS INFECTION;

ADULT; ANTILYMPHOCYTE SERUM; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INSULIN; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLASMAPHERESIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 79953710866     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.147     Document Type: Article

References (11)

1. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F et al. Autologous non-myeloablative hemato-poietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297: 1568-1576. (Pubitemid 46588370)
2. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM et al. C-peptide levels and insulin independence following autologous non-myeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009; 301: 1573-1579.
3. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multi-plex families. Am J Hum Genet 1996; 59: 1134-1148. (Pubitemid 26346356)
4. Shtauvere A, Rumba I, Dzivite I, Sanjeevi CB. HLA-DR and-DQ gene polymorphism in Latvian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1998; 52: 385-388. (Pubitemid 28467014)
5. Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007; 70: 110-127. (Pubitemid 47024833)
6. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008; 57: 1084-1092.
7. Brodsky RA, Jones RJ. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages. Auto-immunity 2008; 41: 596-600.
8. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R et al. Clinical applications of blood-derived and marrow-derived stem cells for non-malignant diseases. JAMA 2008; 299: 925-936. (Pubitemid 351397068)
9. Ludvigsson J, Heding L, Lieden G, Marner B, Lernmark A. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. Br Med J (Clin Res Ed) 1983; 286: 176-178. (Pubitemid 13147594)
10. Bonora E. Protection of pancreatic beta-cells: is it feasible? Nutr Metab Cardiovasc Dis 2008; 18: 74-83. (Pubitemid 50020512)
11. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM et al. C-peptide levels and insulin independence following autologous non-myeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009; 301: 1573-1579.